Table of Contents

7.1 Relevance to the driving task

7.1.1 Effects of psychiatric conditions on driving

Psychiatric conditions may be associated with disturbances of behaviour, cognitive abilities and perception and therefore have the potential to affect driving ability1, 2, 3, 4. They do, however, differ considerably in their aetiology, symptoms and severity, and may be occasional or persistent. The impact of mental illness also varies depending on a person’s social circumstances, occupation and coping strategies. Assessment of fitness to drive must therefore be individualised and should rely on an evaluation of the specific pattern of illness and potential impairments as well as severity, rather than the diagnosis per se. The range of potential impairments for various conditions is described below.

People with schizophrenia may have impairments across many domains of cognitive function including:

  • reduced ability to sustain concentration or attention
  • reduced cognitive and perceptual processing speeds including reaction time reduced ability to perform in complex conditions – for example, when there are multiple distractions
  • perceptual abnormalities – for example, hallucinations that distract attention or are preoccupying
  • delusional beliefs that interfere with driving – for example, persecutory beliefs may include being followed and result in erratic driving, or grandiose beliefs may result in extreme risk taking.

People with bipolar affective condition may demonstrate:

  • depression and suicidal ideation
  • mania or hypomania, with impaired judgement about driving skill and associated recklessness
  • delusional beliefs that directly affect driving.

People with depression may demonstrate:

  • disturbances in attention, information processing and judgement, including reduced ability to anticipate
  • psychomotor retardation and reduced reaction times
  • sleep disturbances and fatigue
  • suicidal ideation that may manifest in reckless driving.

People with anxiety conditions (including post- traumatic stress disorder) may:

  • be preoccupied or distractible
  • experience panic attacks or obsessional behaviours that may impair driving.

People with personality conditions may be:

  • aggressive or impulsive
  • resentful of authority or reckless.

People with attention-deficit/hyperactivity disorder may:

  • be more prone to angry aggressive and risky driving behaviour
  • have difficulty in planning, organising and prioritising tasks
  • have difficulty in sustaining or shifting focus
  • have difficulty managing frustration, modulating emotions and self-regulation.

These impairments are difficult to determine because impairment differs at various phases of the illness and may vary markedly between individuals. The impairments described above are particularly important for commercial vehicle drivers.

7.1.2 Evidence of crash risk

There is limited evidence about the impact of psychiatric illness on crash risk1, 3, 4. Some studies have shown that drivers with psychiatric illness have an increased crash risk compared with drivers without psychiatric illness. There is also specific evidence for increased risk among those with schizophrenia and personality conditions. The evidence suggests a modestly elevated risk for people with low levels of impairment; however, it is possible that people with higher levels of impairment self-regulate their driving or drive more slowly and cautiously, therefore reducing their risk.

7.1.3 Impairments associated with medication

Medications prescribed for treating psychiatric conditions may impair driving performance5. There is, however, little evidence that medication, if taken as prescribed, contributes to crashes; in fact, it may even help reduce the risk of a crash (refer to Part A section 2.2.9. Drugs and driving). Numerous psychotropic medications have been shown to impair perception, vigilance and psychomotor skills. Many medications can produce side effects such as sedation, lethargy, impaired psychomotor function and sleep disturbance. Benzodiazepines have especially been shown to impair vision, attention, information processing, memory, motor coordination and combined-skill tasks. Tolerance to the sedating effects may develop after the first few weeks, although other cognitive impairments may persist. The assessment of medication effects should be individualised and rely upon self- report, observation, clinical assessment and collateral information to determine if particular medications might affect driving. If a person is prescribed stimulants (e.g. dexamphetamine) for treating attention-deficit/hyperactivity disorder, this should be stated in the advice provided to the driver licensing authority.

Health professionals should have heightened concern when sedative medications are prescribed but should also consider the need to treat psychiatric conditions effectively. Refer also to section 9. Substance misuse.